Mohammad Hossein Yadegari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mohammad Hossein Yadegari has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
- Mehdi Mahdavi
The Advanced Therapy Medicinal Product (ATMP) Department is located in Tehran, Iran, at the Breast Cancer Research Center, Motamed Cancer Institute, and the Academic Center for Education, Culture, and Research (ACECR), Iran; Recombinant Vaccine Research Center, Tehran University of Medical Sciences, Tehran, Iran
4 shared publications - Ali Reza Khosravi
Department of Immunology and Microbiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
3 shared publications - Hossein Zarrinfar
Allergy research Center, Mashhad University of Medical Sciences, Mashhad, Iran
3 shared publications - Masoumeh Rajabibazl
Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 shared publications - Abdolamir Allameh
Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
2 shared publications Elahe Sasani
Department of Medical Mycology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 28 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 42633
Chitosan nanoparticles loaded with ribavirin, carboplatin, and thyme oil downregulate SNQ2, ERG11, CDR1, and MDR1 in Candida strains
This study examined the effects of chitosan nanoparticles (CS-NPs) loaded with ribavirin (CS-R-NPs), carboplatin (CS-C-NPs), and Thymus vulgaris essential oil (CS-TV-NPs) on gene expression in Candida glabrata and Candida tropicalis. C. glabrata and C. tropicalis strains were obtained from Tarbiat Modares University. CS-NPs were synthesized via the ionic gelation method and characterized through dynamic light scattering, electrophoretic light scattering and transmission electron microscopy. Cytotoxicity was assessed via the MTT assay in fibroblasts. The minimum inhibitory concentrations (MICs) of the nanoparticle-encapsulated formulations were determined via the microdilution method per the CLSI-M27-A3/S4 guidelines. The gene expression of SNQ2 and ERG11 in C. glabrata and that of CDR1 and MDR1 in C. tropicalis was quantified via qRT‒PCR. CS-R-NPs, CS-C-NPs and CS-TV-NPs demonstrated high encapsulation efficiencies (81–91%), hydrodynamic diameters of approximately 286–298 nm, and positive zeta potentials (+ 33 to + 34 mV), with a spherical morphology and minimal aggregation. In vitro drug release extended over 64 h, with CS-TV-NPs achieving the highest cumulative release (60%). Cytotoxicity assays indicated that the CS-TV-NPs presented the highest IC50 (20.31 µg/ml). Compared with free drugs, encapsulated formulations significantly lowered the MIC values against C. glabrata and C. tropicalis, enhancing antifungal efficacy. qRT‒PCR confirmed notable downregulation of SNQ2 and ERG11 in C. glabrata and of CDR1 and MDR1 in C. tropicalis, with the most pronounced effects observed in the CS-NP-treated groups. CS-NPs significantly enhanced antifungal efficacy by reducing MIC values and downregulating resistance genes, highlighting their potential as effective drug delivery systems against Candida infections.
- 28 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 42633
Open AccessChitosan nanoparticles loaded with ribavirin, carboplatin, and thyme oil downregulate SNQ2, ERG11, CDR1, and MDR1 in Candida strains
This study examined the effects of chitosan nanoparticles (CS-NPs) loaded with ribavirin (CS-R-NPs), carboplatin (CS-C-NPs), and Thymus vulgaris essential oil (CS-TV-NPs) on gene expression in Candida glabrata and Candida tropicalis. C. glabrata and C. tropicalis strains were obtained from Tarbiat Modares University. CS-NPs were synthesized via the ionic gelation method and characterized through dynamic light scattering, electrophoretic light scattering and transmission electron microscopy. Cytotoxicity was assessed via the MTT assay in fibroblasts. The minimum inhibitory concentrations (MICs) of the nanoparticle-encapsulated formulations were determined via the microdilution method per the CLSI-M27-A3/S4 guidelines. The gene expression of SNQ2 and ERG11 in C. glabrata and that of CDR1 and MDR1 in C. tropicalis was quantified via qRT‒PCR. CS-R-NPs, CS-C-NPs and CS-TV-NPs demonstrated high encapsulation efficiencies (81–91%), hydrodynamic diameters of approximately 286–298 nm, and positive zeta potentials (+ 33 to + 34 mV), with a spherical morphology and minimal aggregation. In vitro drug release extended over 64 h, with CS-TV-NPs achieving the highest cumulative release (60%). Cytotoxicity assays indicated that the CS-TV-NPs presented the highest IC50 (20.31 µg/ml). Compared with free drugs, encapsulated formulations significantly lowered the MIC values against C. glabrata and C. tropicalis, enhancing antifungal efficacy. qRT‒PCR confirmed notable downregulation of SNQ2 and ERG11 in C. glabrata and of CDR1 and MDR1 in C. tropicalis, with the most pronounced effects observed in the CS-NP-treated groups. CS-NPs significantly enhanced antifungal efficacy by reducing MIC values and downregulating resistance genes, highlighting their potential as effective drug delivery systems against Candida infections.
- Open Access
- 20 August 2024
- Published by Knowledge E DMCC in Iranian Journal of Microbiology
- Vol. 16 (4) , 560-568
Inhibitory effect of Nigella sativa oil loaded to liposomal nanocarriers on Candida parapsilosis isolates
Background and Objectives: Candida parapsilosis is the second most common species causing infectious diseases and can lead to biofilm resistance. This study aims to adjust and synthesize a liposomal compound of Nigella sativa and evaluate its antifungal properties against C. parapsilosis isolates. Materials and Methods: The liposomal formulation of N. sativa was optimized through the utilization of transmission elec- tron microscopy (TEM), particle size analysis, zeta potential measurement, and UV-visible spectrophotometry. Furthermore, an MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay was conducted on peripheral blood mononu- clear cells (PBMCs). The antifungal efficacy was evaluated in accordance with the M27-A3 guideline. Results: The minimum inhibitory concentrations (MICs) of N. sativa oil and the liposomal formulation on C. parapsilosis isolates ranged from 128 to 8 µg/mL and from 250 to 31.25 µg/mL, respectively. The MIC and MIC values of N. sativa oil and the liposomal formulation were 125, 187, and 32, 96 µg/mL, respectively. The viability percentage of cells treated with the liposomal formulation and free N. sativa oil was 91% and 85%, respectively. Conclusion: The cytotoxicity of free N. sativa was significantly reduced when using nanoliposomes. The liposomal form of N.sativa showed greater antifungal properties compared to the free N. sativa extract against C. parapsilosis isolates.
- 20 August 2024
- Published by Knowledge E DMCC in Iranian Journal of Microbiology
- Vol. 16 (4) , 560-568
Open AccessInhibitory effect of Nigella sativa oil loaded to liposomal nanocarriers on Candida parapsilosis isolates
Background and Objectives: Candida parapsilosis is the second most common species causing infectious diseases and can lead to biofilm resistance. This study aims to adjust and synthesize a liposomal compound of Nigella sativa and evaluate its antifungal properties against C. parapsilosis isolates. Materials and Methods: The liposomal formulation of N. sativa was optimized through the utilization of transmission elec- tron microscopy (TEM), particle size analysis, zeta potential measurement, and UV-visible spectrophotometry. Furthermore, an MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay was conducted on peripheral blood mononu- clear cells (PBMCs). The antifungal efficacy was evaluated in accordance with the M27-A3 guideline. Results: The minimum inhibitory concentrations (MICs) of N. sativa oil and the liposomal formulation on C. parapsilosis isolates ranged from 128 to 8 µg/mL and from 250 to 31.25 µg/mL, respectively. The MIC and MIC values of N. sativa oil and the liposomal formulation were 125, 187, and 32, 96 µg/mL, respectively. The viability percentage of cells treated with the liposomal formulation and free N. sativa oil was 91% and 85%, respectively. Conclusion: The cytotoxicity of free N. sativa was significantly reduced when using nanoliposomes. The liposomal form of N.sativa showed greater antifungal properties compared to the free N. sativa extract against C. parapsilosis isolates.
- Open Access
- 26 December 2023
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 16 (10)
Designing and Synthesis of an Anti-Candida parapsilosis Thymoquinone Lipid Formulation
Background: Candida parapsilosis complex, as an opportunistic pathogen, can cause various infections, especially in immunocompromised patients. Objectives: This study investigated a novel thymoquinone-liposomal nanoparticle to increase the stability of thymoquinone with antifungal effects against C. parapsilosis isolates. Methods: The thymoquinone was encapsulated in liposomal nanoparticles using a thin-film hydration technique and then analyzed by transmission electron microscopy (TEM), particle size, zeta potential, and UV-visible spectrophotometer. Also, the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay was used on peripheral blood mononuclear cells (PBMCs) for cell metabolic activity. The antifungal activity of thymoquinone-liposomal nanoparticle against 15 clinical isolates of C. parapsilosis and the reference strain was examined based on the M27-A3 guideline. Results: The synthesized thymoquinone-liposomal nanoparticle was approved by the TEM, particle size, zeta potential, and UV-Vis. The thymoquinone-liposomal nanoparticle showed no toxic effect on PBMCs following the MTT assay. The minimum inhibitory concentration (MIC) range of free thymoquinone and liposomal formulations with inhibitory effects on Candida isolates was 50 to 6.25 and 150 to 18.75 µg/mL, respectively. The MIC50 and MIC90 values of free thymoquinone and thymoquinone-liposomal nanoparticle were 25 and 50, and 75 and 150 µg/mL. Conclusions: The synthesized thymoquinone-liposomal nanoparticle shows significant antifungal activity against C. parapsilosis isolates compared to free thymoquinone. However, because of its hydrophilicity and hydrophobicity, biocompatibility, particle size, non-toxic effect, and higher cell viability, the thymoquinone-liposomal nanoparticle is a more effective approach for treating fungal infections.
- 26 December 2023
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 16 (10)
Open AccessDesigning and Synthesis of an Anti-Candida parapsilosis Thymoquinone Lipid Formulation
Background: Candida parapsilosis complex, as an opportunistic pathogen, can cause various infections, especially in immunocompromised patients. Objectives: This study investigated a novel thymoquinone-liposomal nanoparticle to increase the stability of thymoquinone with antifungal effects against C. parapsilosis isolates. Methods: The thymoquinone was encapsulated in liposomal nanoparticles using a thin-film hydration technique and then analyzed by transmission electron microscopy (TEM), particle size, zeta potential, and UV-visible spectrophotometer. Also, the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay was used on peripheral blood mononuclear cells (PBMCs) for cell metabolic activity. The antifungal activity of thymoquinone-liposomal nanoparticle against 15 clinical isolates of C. parapsilosis and the reference strain was examined based on the M27-A3 guideline. Results: The synthesized thymoquinone-liposomal nanoparticle was approved by the TEM, particle size, zeta potential, and UV-Vis. The thymoquinone-liposomal nanoparticle showed no toxic effect on PBMCs following the MTT assay. The minimum inhibitory concentration (MIC) range of free thymoquinone and liposomal formulations with inhibitory effects on Candida isolates was 50 to 6.25 and 150 to 18.75 µg/mL, respectively. The MIC50 and MIC90 values of free thymoquinone and thymoquinone-liposomal nanoparticle were 25 and 50, and 75 and 150 µg/mL. Conclusions: The synthesized thymoquinone-liposomal nanoparticle shows significant antifungal activity against C. parapsilosis isolates compared to free thymoquinone. However, because of its hydrophilicity and hydrophobicity, biocompatibility, particle size, non-toxic effect, and higher cell viability, the thymoquinone-liposomal nanoparticle is a more effective approach for treating fungal infections.
- Open Access
- 28 June 2023
- Published by MDPI AG in Preprints.org
Inhibitory Effect Evaluation of Nigella sativa Oil Loaded to Liposomal Nanocarriers against Candida parapsilosis Isolates
The aim of current study is adjusted and synthesized liposomal compound of N. sativa and evaluation its antifungal properties against C. parapsilosis isolates. Fifteen clinical isolates of C. parapsilosis complex isolates were obtained from hospitalized patients affected by candidemia in Mashhad city, Iran, along with a reference strain of C. parapsilosis (ATCC 22019) were assessed by flight mass spectrometry (MALDI-TOF) method, as described previously. N. sativa is encapsulated in liposomal Nanocariers by using thin film hydration technique. At the beginning liposomal nanoparticles was characterized and confirmed with the dynamic light scattering technique (DLS) and Transmission electron microscopy. Then minimum inhibitory concentration of liposomal N. sativa oil was conducted with the CLSI M27 A3 protocol and finally Cytotoxicity function of N. sativa oil liposomal nanocarriers on PBMCs was investigated and confirmed with MTT assay by the results of this research N. sativa oil-Lip-NP didn’t show any toxic effect on PBMCs and The minimum inhibitory concentration (MIC) range of free N. sativa oil and liposomal formulation with inhibitory effects on candida isolates was between 128 - 8, 250 - 31.25 µg ml also MIC50 and MIC90 were 125,187 and 32,96, µg ml respectively. Due to the hydrophobicity and hydrophilicity, biocompatibility, particle size, non-toxic effect, and higher cell viability of N. sativa oil -Lip-NP, it could be considered a more effective approach to treating fungal infections.
- 28 June 2023
- Published by MDPI AG in Preprints.org
Open AccessInhibitory Effect Evaluation of Nigella sativa Oil Loaded to Liposomal Nanocarriers against Candida parapsilosis Isolates
The aim of current study is adjusted and synthesized liposomal compound of N. sativa and evaluation its antifungal properties against C. parapsilosis isolates. Fifteen clinical isolates of C. parapsilosis complex isolates were obtained from hospitalized patients affected by candidemia in Mashhad city, Iran, along with a reference strain of C. parapsilosis (ATCC 22019) were assessed by flight mass spectrometry (MALDI-TOF) method, as described previously. N. sativa is encapsulated in liposomal Nanocariers by using thin film hydration technique. At the beginning liposomal nanoparticles was characterized and confirmed with the dynamic light scattering technique (DLS) and Transmission electron microscopy. Then minimum inhibitory concentration of liposomal N. sativa oil was conducted with the CLSI M27 A3 protocol and finally Cytotoxicity function of N. sativa oil liposomal nanocarriers on PBMCs was investigated and confirmed with MTT assay by the results of this research N. sativa oil-Lip-NP didn’t show any toxic effect on PBMCs and The minimum inhibitory concentration (MIC) range of free N. sativa oil and liposomal formulation with inhibitory effects on candida isolates was between 128 - 8, 250 - 31.25 µg ml also MIC50 and MIC90 were 125,187 and 32,96, µg ml respectively. Due to the hydrophobicity and hydrophilicity, biocompatibility, particle size, non-toxic effect, and higher cell viability of N. sativa oil -Lip-NP, it could be considered a more effective approach to treating fungal infections.
- Open Access
- 1 September 2022
- Published by CMV Verlag in Infection Epidemiology and Microbiology
- Vol. 8 (3) , 243-249
Assessment of Antifungal Activity of Saccharomyces boulardii against Candida albicans Biofilm
Backgrounds: The fungal pathogen Candida albicans is a cause of biofilm formation in patients with oropharyngeal candidiasis. Saccharomyces boulardii is a nonpathogenic fungal probiotic that plays an important role in preventing or treating intestinal diseases. This research aimed to determine the inhibitory effect of S. boulardii probiotic yeast on biofilm formation capacity ...
- 1 September 2022
- Published by CMV Verlag in Infection Epidemiology and Microbiology
- Vol. 8 (3) , 243-249
Open AccessAssessment of Antifungal Activity of Saccharomyces boulardii against Candida albicans Biofilm
Backgrounds: The fungal pathogen Candida albicans is a cause of biofilm formation in patients with oropharyngeal candidiasis. Saccharomyces boulardii is a nonpathogenic fungal probiotic that plays an important role in preventing or treating intestinal diseases. This research aimed to determine the inhibitory effect of S. boulardii probiotic yeast on biofilm formation capacity ...
- 19 August 2021
- Published by Springer Nature in Mycopathologia
- Vol. 186 (6) , 847-856
Virulence Factors and Azole-Resistant Mechanism of Candida Tropicalis Isolated from Candidemia
Background Limited knowledge exists on the virulence factors of Candida tropicalis and the mechanisms of azole resistance that lead to an intensified pathogenicity and treatment failure. We aimed to evaluate the virulence factors and molecular mechanisms of azole resistance among C. tropicalis isolated from patients with candidemia. Materials and Methods Several virulence factors, including extracellular enzymatic activities, cell surface hydrophobicity (CSH), and biofilm formation, were evaluated. Antifungal susceptibility pattern and expression level of ERG11, UPC2, MDR1, and CDR1 genes of eight (4 fluconazole resistance and 4 fluconazole susceptible) clinical C. tropicalis isolates were assessed. The correlation between the virulence factors and antifungal susceptibility patterns was analyzed. Results During a 4 year study, forty-five C. tropicalis isolates were recovered from candidemia patients. The isolates expressed different frequencies of virulence determinants as follows: coagulase 4 (8.9%), phospholipase 5 (11.1%), proteinase 31 (68.9%), esterase 43 (95.6%), hemolysin 44 (97.8%), biofilm formation 45 (100%) and CSH 45(100%). All the isolates were susceptible to amphotericin B and showed the highest resistance to voriconazole. There was a significant positive correlation between micafungin minimum inhibitory concentrations (MICs) and hemolysin production (rs = 0.316). However, we found a negative correlation between fluconazole MICs and esterase production (rs = −0.383). We observed the high expression of ERG11 and UPC2 genes in fluconazole-resistant C. tropicalis isolates. Conclusion C. tropicalis isolated from candidemia patients extensively displayed capacities for biofilm formation, hemolysis, esterase activity, and hydrophobicity. In addition, the overexpression of ERG11 and UPC2 genes was considered one of the possible mechanisms of azole resistance.
- 19 August 2021
- Published by Springer Nature in Mycopathologia
- Vol. 186 (6) , 847-856
Virulence Factors and Azole-Resistant Mechanism of Candida Tropicalis Isolated from Candidemia
Background Limited knowledge exists on the virulence factors of Candida tropicalis and the mechanisms of azole resistance that lead to an intensified pathogenicity and treatment failure. We aimed to evaluate the virulence factors and molecular mechanisms of azole resistance among C. tropicalis isolated from patients with candidemia. Materials and Methods Several virulence factors, including extracellular enzymatic activities, cell surface hydrophobicity (CSH), and biofilm formation, were evaluated. Antifungal susceptibility pattern and expression level of ERG11, UPC2, MDR1, and CDR1 genes of eight (4 fluconazole resistance and 4 fluconazole susceptible) clinical C. tropicalis isolates were assessed. The correlation between the virulence factors and antifungal susceptibility patterns was analyzed. Results During a 4 year study, forty-five C. tropicalis isolates were recovered from candidemia patients. The isolates expressed different frequencies of virulence determinants as follows: coagulase 4 (8.9%), phospholipase 5 (11.1%), proteinase 31 (68.9%), esterase 43 (95.6%), hemolysin 44 (97.8%), biofilm formation 45 (100%) and CSH 45(100%). All the isolates were susceptible to amphotericin B and showed the highest resistance to voriconazole. There was a significant positive correlation between micafungin minimum inhibitory concentrations (MICs) and hemolysin production (rs = 0.316). However, we found a negative correlation between fluconazole MICs and esterase production (rs = −0.383). We observed the high expression of ERG11 and UPC2 genes in fluconazole-resistant C. tropicalis isolates. Conclusion C. tropicalis isolated from candidemia patients extensively displayed capacities for biofilm formation, hemolysis, esterase activity, and hydrophobicity. In addition, the overexpression of ERG11 and UPC2 genes was considered one of the possible mechanisms of azole resistance.
- 1 June 2021
- Published by Elsevier in Microbial Pathogenesis
- Vol. 155, 104889
The relationship between biofilm formation and mortality in patients with Candida tropicalis candidemia
- 1 June 2021
- Published by Elsevier in Microbial Pathogenesis
- Vol. 155, 104889
The relationship between biofilm formation and mortality in patients with Candida tropicalis candidemia
- 1 April 2019
- Published by Elsevier in Journal of Medical Mycology
- Vol. 29 (1) , 49-55
Systemic infection with Candida albicans in breast tumor bearing mice: Cytokines dysregulation and induction of regulatory T cells
- 1 April 2019
- Published by Elsevier in Journal of Medical Mycology
- Vol. 29 (1) , 49-55
Systemic infection with Candida albicans in breast tumor bearing mice: Cytokines dysregulation and induction of regulatory T cells